Monday, 31 May 2010

Foscan




Foscan may be available in the countries listed below.


Ingredient matches for Foscan



Temoporfin

Temoporfin is reported as an ingredient of Foscan in the following countries:


  • Belgium

  • Denmark

  • Germany

  • Greece

  • Hungary

  • Israel

  • Luxembourg

  • Slovakia

  • United Kingdom

International Drug Name Search

Friday, 28 May 2010

Calcoral




Calcoral may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Calcoral



Calcium Chloride

Calcium Chloride is reported as an ingredient of Calcoral in the following countries:


  • New Zealand

Calcium Chloride hexahydrate (a derivative of Calcium Chloride) is reported as an ingredient of Calcoral in the following countries:


  • Australia

International Drug Name Search

Friday, 21 May 2010

Estratest




In the US, Estratest (esterified estrogens/methyltestosterone systemic) is a member of the drug class sex hormone combinations and is used to treat Hot Flashes, Menopausal Disorders and Postmenopausal Symptoms.

US matches:

  • Estratest

  • Estratest H.S.

Ingredient matches for Estratest



Conjugated Estrogens

Estrogens, conjugated is reported as an ingredient of Estratest in the following countries:


  • United States

Methyltestosterone

Methyltestosterone is reported as an ingredient of Estratest in the following countries:


  • United States

International Drug Name Search

Tuesday, 18 May 2010

Estring




In the US, Estring (estradiol systemic) is a member of the following drug classes: estrogens, miscellaneous vaginal agents and is used to treat Atrophic Urethritis, Atrophic Vaginitis and Hypoestrogenism.

US matches:

  • Estring Ring

  • Estring local

  • Estring topical

  • Estring

UK matches:

  • Estring (SPC)

Ingredient matches for Estring



Estradiol

Estradiol is reported as an ingredient of Estring in the following countries:


  • Canada

  • Denmark

  • Singapore

  • United States

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Estring in the following countries:


  • Finland

  • Germany

  • Iceland

  • South Africa

  • Switzerland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 13 May 2010

Elitan




Elitan may be available in the countries listed below.


Ingredient matches for Elitan



Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Elitan in the following countries:


  • Malta

  • Oman

International Drug Name Search

Saturday, 8 May 2010

brompheniramine


Generic Name: brompheniramine (brome feh NEER a meen)

Brand names: BroveX, BroveX CT, Dimetane, Dimetane Extentab, Dimetapp Allergy, Dimetapp Allergy Liquigel, Lodrane 12 Hour, ...show all 28 brand names.


What is brompheniramine?

Brompheniramine is an antihistamine. Brompheniramine blocks the effects of the naturally occurring chemical histamine in the body.


Brompheniramine is used to sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold.


Brompheniramine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about brompheniramine?


Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine. Do not crush, chew, or break the extended- or timed-release forms of brompheniramine. Swallow them whole. They are specially formulated to release the medication slowly in the body.

What should I discuss with my healthcare provider before taking brompheniramine?


Do not take brompheniramine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Before taking brompheniramine, talk to your doctor if you have



  • glaucoma or increased pressure in the eye;




  • a stomach ulcer;




  • an enlarged prostate, bladder problems or difficulty urinating;




  • an overactive thyroid (hyperthyroidism);




  • hypertension or any type of heart problems; or




  • asthma.



You may not be able to take brompheniramine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.


Brompheniramine is in the FDA pregnancy category C. This means that it is not known whether brompheniramine will be harmful to an unborn baby. Do not take brompheniramine without first talking to your doctor if you are pregnant or could become pregnant during treatment. Brompheniramine passes into breast milk. Infants are especially sensitive to the effects of antihistamines, and serious side effects could occur in a nursing infant. Do not take brompheniramine without first talking to your doctor if you are nursing a baby. If you are over 60 years of age, you may be more likely to experience side effects from brompheniramine. You may require a lower dose of this medication.

How should I take brompheniramine?


Take brompheniramine exactly as directed on the package or as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water.

Brompheniramine can be taken with or without food.


Do not crush, chew, or break the extended- or timed-release forms of brompheniramine. Swallow them whole. They are specially formulated to release the medication slowly in the body.

To ensure that you get a correct dose, measure the liquid form of brompheniramine with a special dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.


Do not take more of this medication than is prescribed or is recommended on the package. The maximum amount of brompheniramine that you should take in 1 day is 24 mg. The regular-release tablets and the syrup are usually taken every 4 to 6 hours as needed (four to six times a day). The sustained-release tablets and capsules are usually taken every 8 to 12 hours as needed (two or three times a day). If your symptoms do not improve, or if they worsen, contact your healthcare provider. Store brompheniramine at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication unless otherwise directed by your doctor.


What happens if I overdose?


Seek emergency medical attention if an overdose is suspected.

Symptoms of a brompheniramine overdose may include extreme sleepiness, confusion, weakness, ringing in the ears, blurred vision, large pupils, dry mouth, flushing, fever, shaking, insomnia, hallucinations, and possibly seizures.


What should I avoid while taking brompheniramine?


Do not take other over-the-counter cough, cold, allergy, diet, pain, or sleep medications while taking brompheniramine without first talking to your pharmacist or doctor. Other medications may also contain brompheniramine or other similar drugs, and you may accidentally take too much of these medicines.


Brompheniramine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine is taken with any of these medications.


Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine.

Brompheniramine side effects


Stop taking brompheniramine and seek emergency medical attention if you experience a rare but serious allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take brompheniramine and talk to your doctor if you experience



  • sleepiness, fatigue, or dizziness;




  • headache;




  • dry mouth; or




  • difficulty urinating or an enlarged prostate.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.


Brompheniramine Dosing Information


Usual Adult Dose for Cold Symptoms:

Immediate Release: 4 mg to 8 mg orally every 6 hours as needed. The duration of action varies from patient to patient. Many patients will require dosing only twice daily.

Extended Release: 6 mg to 12 mg extended release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

Maximum oral dose 24 mg/day.

Usual Adult Dose for Allergic Rhinitis:

Immediate Release: 4 mg to 8 mg orally every 6 hours as needed. The duration of action varies from patient to patient. Many patients will require dosing only twice daily.

Extended Release: 6 mg to 12 mg extended release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

Maximum oral dose 24 mg/day.

Usual Adult Dose for Urticaria:

Immediate Release: 4 mg to 8 mg orally every 6 hours as needed. The duration of action varies from patient to patient. Many patients will require dosing only twice daily.

Extended Release: 6 mg to 12 mg extended release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

Maximum oral dose 24 mg/day.

Usual Adult Dose for Allergic Reaction:

Immediate Release: 4 mg to 8 mg orally every 6 hours as needed. The duration of action varies from patient to patient. Many patients will require dosing only twice daily.

Extended Release: 6 mg to mg 12 mg extended release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

Maximum oral dose 24 mg/day.

IV, IM, subcutaneous: 5 mg to 20 mg every 6 to 12 hours. Duration of action is 3 to 12 hours.
Maximum parenteral dose 40 mg/day.

Usual Pediatric Dose for Allergic Rhinitis:

Immediate Release:
0.125 mg/kg/dose orally every 6 hours. Maximum dose: 6 mg to 8 mg/day.

2 to 6 years:
Extended Release suspension:
2 mg orally twice daily, not to exceed 2 doses in 24 hours.

6 to 12 years:
Immediate Release:
2 mg to 4 mg orally every 6 to 8 hours. Maximum dose 12 to 16 mg/day.
Extended Release suspension:
4 mg orally twice daily, not to exceed 2 doses in 24 hours.

> 12 years:
Immediate Release:
4 mg to 8 mg orally every 6 hours as needed. The duration of action varies from patient to patient. Many patients will require dosing only twice daily.
Extended Release:
6 mg to 12 mg sustained release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

Maximum oral dose 24 mg/day.

Usual Pediatric Dose for Cold Symptoms:

Immediate Release:
0.125 mg/kg/dose orally every 6 hours. Maximum dose: 6 mg to 8 mg/day.

2 to 6 years:
Extended Release suspension:
2 mg orally twice daily, not to exceed 2 doses in 24 hours.

6 to 12 years:
Immediate Release:
2 mg to 4 mg orally every 6 to 8 hours. Maximum dose 12 to 16 mg/day.
Extended Release suspension:
4 mg orally twice daily, not to exceed 2 doses in 24 hours.

> 12 years:
Immediate Release:
4 mg to 8 mg orally every 6 hours as needed. The duration of action varies from patient to patient. Many patients will require dosing only twice daily.
Extended Release:
6 mg to 12 mg sustained release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

Maximum oral dose 24 mg/day.

Usual Pediatric Dose for Urticaria:

Immediate Release:
0.125 mg/kg/dose orally every 6 hours. Maximum dose: 6 mg to 8 mg/day.

2 to 6 years:
Extended Release suspension:
2 mg orally twice daily, not to exceed 2 doses in 24 hours.

6 to 12 years:
Immediate Release:
2 mg to 4 mg orally every 6 to 8 hours. Maximum dose 12 to 16 mg/day.
Extended Release suspension:
4 mg orally twice daily, not to exceed 2 doses in 24 hours.

> 12 years:
Immediate Release:
4 mg to 8 mg orally every 6 hours as needed. The duration of action varies from patient to patient. Many patients will require dosing only twice daily.
Extended Release:
6 mg to 12 mg sustained release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

Maximum oral dose 24 mg/day.

Usual Pediatric Dose for Allergic Reaction:

Immediate Release:
0.125 mg/kg/dose orally every 6 hours. Maximum dose: 6 mg to 8 mg/day.

2 to 6 yrs:
Extended Release Suspension:
2.5 mg extended release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

6 to 12 years:
Immediate Release:
2 mg to 4 mg orally every 6 to 8 hours. Maximum dose 12 to 16 mg/day.
Extended Release Suspension:
5 mg extended release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.


> 12 years:
Immediate Release:
4 mg orally every 6 hours as needed. The duration of action varies from patient to patient. Many patients will require dosing only twice daily.
Extended Release:
6 mg to 12 mg extended release orally twice daily as needed. The duration of action varies from patient to patient. Many patients will require dosing only once a day, preferably at bedtime to avoid drowsiness.

Maximum oral dose 24 mg/day.

IM, IV, subcutaneous :
0.5 mg/kg/day divided every 6 to 8 hours.

> 12 years:
5 mg to 20 mg every 6 to 12 hours. Duration of action is 3 to 12 hours.
Maximum parenteral dose 40 mg/day.


What other drugs will affect brompheniramine?


Do not take brompheniramine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Do not take other over-the-counter cough, cold, allergy, diet, pain, or sleep medications while taking brompheniramine without first talking to your pharmacist or doctor. Other medications may also contain brompheniramine or other similar drugs, and you may accidentally take too much of these medicines.


Brompheniramine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine is taken with any of these medications.


Drugs other than those listed here may also interact with brompheniramine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including vitamins, minerals, and herbal products.



More brompheniramine resources


  • Brompheniramine Side Effects (in more detail)
  • Brompheniramine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Brompheniramine Drug Interactions
  • Brompheniramine Support Group
  • 6 Reviews for Brompheniramine - Add your own review/rating


  • Brompheniramine 12-Hour Sustained-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Brompheniramine Professional Patient Advice (Wolters Kluwer)

  • Brompheniramine Maleate, Dexbrompheniramine Maleate Monograph (AHFS DI)

  • Brovex Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Brovex CT Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lodrane 24 24-Hour Sustained-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • VaZol Liquid MedFacts Consumer Leaflet (Wolters Kluwer)



Compare brompheniramine with other medications


  • Allergic Reactions
  • Cold Symptoms
  • Hay Fever
  • Urticaria


Where can I get more information?


  • Your pharmacist has more information about brompheniramine written for health professionals that you may read.

See also: brompheniramine side effects (in more detail)


Etidronic Acid




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M05BA01

CAS registry number (Chemical Abstracts Service)

0002809-21-4

Chemical Formula

C2-H8-O7-P2

Molecular Weight

206

Therapeutic Category

Calcium regulator

Chemical Name

Phosphonic acid, (1-hydroxyethylidene)bis-

Foreign Names

  • Acidum etidronicum (Latin)
  • Etidronsäure (German)
  • Acide étidronique (French)
  • Acido etidronico (Spanish)

Generic Names

  • Acide étidronique (OS: DCF)
  • Acido etidronico (OS: DCIT)
  • Etidronic Acid (OS: BAN, USAN)
  • EHDP (IS)
  • Disodium Etidronate (OS: BANM)
  • Etidronate Disodium (OS: USAN)
  • Etidronsäure dinatrium (IS)
  • Dinatrii etidronas (PH: Ph. Eur. 6)
  • Etidronate Disodium (PH: BP 2010, Ph. Eur. 6, USP 32)

Brand Names

  • CO Etidronate
    Cobalt, Canada


  • Anfozan
    Proel, Greece


  • CO Etidrocal (Etidronic Acid and Calcium Carbonate)
    Cobalt, Canada


  • Didrocal (Etidronic Acid and Calcium Carbonate)
    Pfizer, Australia; Procter & Gamble, Canada


  • Didrokit (Etidronic Acid and Calcium Carbonate)
    Combiphar, Netherlands; Dr. Fisher, Netherlands; EU-Pharma, Netherlands; Euro, Netherlands; Procter & Gamble, Netherlands


  • Didronat
    Koçak, Turkey


  • Didronate/Calcium Procter & Gamble (Etidronic Acid and Calcium Carbonate)
    Procter&Gamble, Denmark


  • Didronate
    Procter & Gamble, Finland; Procter & Gamble, Iceland; Procter & Gamble, Norway; Procter & Gamble, Sweden; Procter&Gamble, Denmark


  • Didronate + Calcium (Etidronic Acid and Calcium Carbonate)
    Procter & Gamble, Finland


  • Didronel Europharma DK
    Procter&Gamble, Denmark


  • Didronel Orifarm
    Procter&Gamble, Denmark


  • Didronel Paranova
    Procter&Gamble, Denmark


  • Didronel
    Dainippon Sumitomo, Japan; Pfizer, Australia; Pfizer, New Zealand; Procter & Gamble, Canada; Procter & Gamble, Germany; Procter & Gamble, France; Procter & Gamble, United Kingdom; Procter & Gamble, Ireland; Procter & Gamble, Israel; Procter & Gamble, Luxembourg; Procter & Gamble, Tunisia; Procter & Gamble, United States; Sanofi-Aventis, Austria


  • Didronel (veterinary use)
    Procter & Gamble Animals, United Kingdom


  • Didronel PMO (Etidronic Acid and Calcium Carbonate)
    Procter & Gamble, United Kingdom


  • Didronel-Kit (Etidronic Acid and Calcium Carbonate)
    Procter & Gamble, Germany


  • Difosfen
    Inmunosyn, Colombia; Omedir, Argentina; Rubio, Spain; Rubio, Poland; Rubio, Singapore


  • Diphos
    Procter & Gamble, Germany


  • Dronate-Os
    BDH, India


  • Etidrate
    Pacific, New Zealand


  • Etidron Hexal
    Hexal, Germany


  • Etidron
    Abiogen, Italy


  • Etidronat Jenapharm
    Mibe Jena, Germany


  • Etidronate Disodium
    Mylan, United States


  • Etidronate Mylan
    Mylan, France


  • Etidronate Sandoz
    Sandoz, France


  • Etiplus
    Biospray, Greece


  • Feminoflex
    Medicus, Greece


  • Gen-Eti-Cal Carepac (Etidronic Acid and Calcium Carbonate)
    Genpharm, Canada


  • Gen-Etidronate
    Genpharm, Canada


  • Maxibral
    Demo, Greece


  • Oflocin
    Farmedia, Greece


  • Osfo
    Gap, Greece


  • Ostedron
    ICN, Poland; Kleva, Greece


  • Osteodidronel
    Procter & Gamble, Belgium


  • Osteodrug
    Med-One, Greece


  • Osteoton
    png Gerolymatos, Greece


  • Osteum
    Viñas, Spain


  • Ostogene
    Genepharm, Greece


  • Ostopor
    Uni-Pharma, Greece


  • Somaflex
    Cosmopharm, Greece


  • Sviroxit
    Rafarm, Greece


  • Tilferan
    Vocate, Greece

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Penicilline G Sodique




Penicilline G Sodique may be available in the countries listed below.


Ingredient matches for Penicilline G Sodique



Benzylpenicillin

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Penicilline G Sodique in the following countries:


  • Tunisia

International Drug Name Search

Thursday, 6 May 2010

Etaconil




Etaconil may be available in the countries listed below.


Ingredient matches for Etaconil



Flutamide

Flutamide is reported as an ingredient of Etaconil in the following countries:


  • Chile

  • Peru

  • Venezuela

International Drug Name Search

Wednesday, 5 May 2010

Fixim




Fixim may be available in the countries listed below.


Ingredient matches for Fixim



Cefixime

Cefixime trihydrate (a derivative of Cefixime) is reported as an ingredient of Fixim in the following countries:


  • Costa Rica

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

International Drug Name Search

Sunday, 2 May 2010

Pancreatic Secretion Medications


Drugs associated with Pancreatic Secretion

The following drugs and medications are in some way related to, or used in the treatment of Pancreatic Secretion. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List: